1:30 pm

Existing Frameworks for Biomarker Qualification—PhRMA—James Mayne

2:00 pm

NIH Biomarker Qualification/Cancer Perspective—Arthur Schatzkin

2:30 pm

Risk Factor to Surrogate Endpoint Pathway—Philip Greenland

3:00 pm


3:30 pm


3:45 pm

Troponin—James de Lemos

4:15 pm

CRP and Inflammatory Markers—Christie Ballantyne

4:45 pm

HDL/LDL—Bryan Brewer

5:15 pm

Case Studies Discussion Speakers and Committee

5:45 pm


The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement